U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Bizarre Patents

Patent No. 5571247

Self Containing Enclosure for Protection from Killer Bees

A self contained protective enclosure with an opening for entry and egress and a screen for ventilation and viewing.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 549/488 - Additional chalcogen attached indirectly to the hetero ring by nonionic bonding


Subclass of Class 549 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein an additional chalcogen (i.e., oxygen,
No. of patents: 136
Last issue date: 11/15/2011


1        
NumberTitleIssue Date
8058458Processes for the preparation and purification of hydroxymethylfuraldehyde derivatives
A method for utilizing an industrially convenient fructose source for a dehydration reaction converting a carbohydrate to a furan derivative is provided. Recovery methods also are provided. Embodiments of the methods improve upon the known methods of producing furan...
11/15/2011
7956203Oxidation of 5-(hydroxymethyl) furfural to 2,5-diformylfuran and subsequent decarbonylation to unsubstituted furan
Alcohols are catalytically oxidized to aldehydes, in particular to benzaldehyde and diformylfuran, which are useful as intermediates for a multiplicity of purposes. The invention also relates to the polymerization of the dialdehyde and to the decarbonylation of the ...
06/07/2011
7939681Methods for conversion of carbohydrates in ionic liquids to value-added chemicals
Methods are described for converting carbohydrates including, e.g., monosaccharides, disaccharides, and polysaccharides in ionic liquids to value-added chemicals including furans, useful as chemical intermediates and/or feedstocks. Fructose is converted to 5-hydroxy...
05/10/2011
7897794Method for purifying hydroxymethylfurfural using non-functional polymeric resins
Disclosed are methods of at least partially purifying HMF from an aqueous mixture containing reactants and products of HMF synthesis from fructose that relies on use of non-functional polymeric resins. A first type of non-functional polymeric resin preferentially ad...
03/01/2011
7579489Processes for the preparation and purification of hydroxymethylfuraldehyde and derivatives
A method for utilizing an industrially convenient fructose source for a dehydration reaction converting a carbohydrate to a furan derivative is provided. Recovery methods also are provided. Embodiments of the methods improve upon the known methods of producing furan...
08/25/2009
7572925Catalytic process for producing furan derivatives in a biphasic reactor
Described is a catalytic process for converting sugars to furan derivatives (e.g. 5-hydroxymethylfurfural, furfural, dimethylfuran, etc.) using a biphasic reactor containing a reactive aqueous phase and an organic extracting phase. The process provides a cost-effect...
08/11/2009
7411078Method for producing furan-2,5-dicarboxylic acid
A method for producing furan-2,5-dicarboxylic acid (FDCA) is provided which can efficiently and quantitatively producing FDCA under mild conditions, without employing an expensive catalyst and with a reduced energy consumption. A furan ring compound having two funct...
08/12/2008
7101878Non-peptide GNRH agents, methods and intermediates for their preparation
Non-peptide GnRH agents capable of inhibiting the effect of gonadotropin-releasing hormone are described. Such compounds and their pharmaceutically acceptable salts, multimers, prodrugs, and active metabolites are suitable for treating mammalian reproductive disorde...
09/05/2006
7019024Pharmaceutical for treatment of neurological and neuropsychiatric disorders
The invention provides a pharmaceutical for treatment of neurological and neuropsychiatric disorders comprising a compound of the formula: or a pharmaceutically acceptable salt thereof. ...
03/28/2006
6963010Hydrophobic polyamine analogs and methods for their use
The disclosed invention provides new polyamine analogs and derivatives containing a hydrophobic region and a polyamine region as well as methods and compositions for their use. ...
11/08/2005
6603026Heterocyclic compounds produced from biomass
Sugars derived from acidic hydrolysis of biomass consist of glucose and xyloses which are subjected to dehydration, within the hydrolysis environment, to form heterocyclic compounds, furfural and hydroxymethylfurfural. By providing a vessel for hydrolysis...
08/05/2003
65899706-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
This invention provides novel compounds, pharmaceutical compositions and methods of treating thrombotic disorders in mammals, the compounds having the formula: ##STR1## Wherein: Ar is phenyl, naphthyl, furanyl, benzofuranyl, indolyl, pyrazolyl, oxazo...
07/08/2003
6420392Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
2,5-Diaryl tetrahydrofurans, 2,5-diaryl tetrahydrothiophenes, 1,3-diaryl cyclopentanes are disclosed that reduce the chemotaxis and respiratory burst leading to the formation of damaging oxygen radicals of polymorphonuclear leukocytes during an inflammato...
07/16/2002
6369225Compounds having activity as inhibitors of cytochrome P450RAI
Compounds having Formula 8 wherein the symbols have the meaning defined in the specification are inhibitors of the cytochrome P450RAI (retinoic acid inducible) enzyme, and are used for treating diseases responsive to treatment by retinoids. ##STR1##...
04/09/2002
6362166Antipicornaviral compounds and methods for their use and preparation
Picornaviral 3C protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of picornaviral 3C proteases. These compounds, as well as pharmaceutical compositions that contain these compounds, are suitable for treating p...
03/26/2002
6353119Preparation of 3-substituted-4-arylquinolin-2-one derivatives
The present invention relates to a process for the preparation of 3-substituted-4-arylquinolin-2-one derivatives from a substituted coumarin and using a photochemical cyclization method on a dihydrofuran intermediate....
03/05/2002
6255340Pesticidal composition
A pesticidal composition comprising prallethrin and a neonicotinoid compound given in the following formula (1), (2) or (3), as an active ingredient ##STR1## wherein, A represents a 6-chloro-3-pyridyl, 2-chloro-5-thiazolyl, tetrahydrofuran-2-yl, tetr...
07/03/2001
61503975-aroylnaphthalene derivatives as anti-inflammatory agents
The present invention relates to certain 5-aroylnaphthalene derivatives of formula (I): ##STR1## that are inhibitors of prostaglandin G/H synthase, pharmaceutical compositions containing them, methods for their use, and methods for preparing the...
11/21/2000
6127576Aminophenyl ketone derivatives and a method for the preparation thereof
The present invention provides o-aminophenyl ketone derivatives which are intermediates useful in the manufacture of herbicidal sulfamoyl urea compounds, including the crop selective herbicide 1-{[o-(cyclopropylcarbonyl)phenyl]-sulfamoyl}-3-(4,6-dimethoxy...
10/03/2000
6124502Mercaptoketones and mercaptoalcohols and a process for their preparation
This invention relates to matrix metalloproteinase (MMP) inhibiting compounds of the formula: ##STR1## where R1 is C1 -C12 alkyl, straight or branched and optionally substituted by halogen, hydroxy, C1 -C
09/26/2000
6103708Furans, benzofurans, and thiophenes useful in the treatment of insulin resistance and hyperglycemia
This invention provides compounds of Formula I having the structure: ##STR1## wherein R1, R2, R3, R4, R5, R6, R7, R8, W, X, Y, and Z are as defined in the specificatio...
08/15/2000
6100253Tricycle substituted with azaheterocyclic carboxylic acids
The present invention relates to novel N-substituted azaheterocyclic compounds of the general formula ##STR1## wherein X, Y, Z, R1, R2 and r are as defined in the detailed part of the present description, or salts thereof, to me...
08/08/2000
6054611Method for the production of levulinic acid and its derivatives
A method of producing dehydration products from one more 5-carbon or 6-carbon sugars includes reacting said one or more sugars at 40-240° C. for 1 to 96 hours in the presence of 5-90% sulfuric acid, separating the reaction products, and recovering levuli...
04/25/2000
6037367Substituted-pent-4-ynoic acids
Compounds of formula (I) wherein: R1 is --(CR4 R5)n C(O)O(CR4 R5)m R6, --(CR4 R5)n C(O)NR4 (CR4 R5)m
03/14/2000
5905166Type of dye in photographic materials
A new type of yellow dyes with general formula Q-CO--CO--X is disclosed. They can be used in photographic materials as antihalation dyes, acutance dyes or filter dyes. Preferably they are incorporated in UV sensitive contact materials for pre-press applic...
05/18/1999
5856530Antipicornaviral compounds and methods for their use and preparation
Picornaviral 3C protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of picornaviral 3C proteases. These compounds, as well as pharmaceutical compositions that contain these compounds, are suitable for treating p...
01/05/1999
5856323Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
2,5-Diaryl tetrahydrofurans, 2,5-diaryl tetrahydrothiophenes, 2,4-diaryl tetrahydrofurans, 2,4-diaryl tetrahydrothiophenes, 1,3-diaryl cyclopentanes, 2,4-diaryl pyrrolidines, and 2,5-diaryl pyrrolidines are disclosed that reduce the chemotaxis and respira...
01/05/1999
5716624Polyaromatic propynyl compounds and pharmaceutical/cosmetic compositions comprised thereof
Novel pharmaceutically/cosmetically-active polyaromatic propynyl compounds have the structural formula (1): ##STR1## in which X is one of the radicals: ##STR2## and are useful for the treatment of a wide variety of disease states, whether h...
02/10/1998
5663199Anti-viral aromatic O-alkylated oximes, ethers and thioethers
Compounds of the formula ##STR1## wherein Q is ##STR2## R1 is hydrogen or halogen R2 is hydrogen or halogen; R3 is hydrogen or C1 -C4 alkyl; R4 is C3 -C6 alkenyl ...
09/02/1997
5648486Compounds and methods for the treatment of inflammatory and immune disorders
2,5-Diaryl tetrahydrofurans, 2,5-diaryl tetrahydrothiophenes, 2,4-diaryl tetrahydrofurans, 2,4-diaryl tetrahydrothiophenes, 1,3-diaryl cyclopentanes, 2,4-diaryl pyrrolidines, and 2,5-diaryl pyrrolidines are disclosed that reduce the chemotaxis and respira...
07/15/1997
5610320Sulfonamide phenyl substituted compounds
Sulfonamide compounds of the formula or pharmacologically acceptable salts thereof: ##STR1## wherein: R1 is a hydrogen atom, halogen atom, lower alkyl group, lower alkoxy group, hydroxyl group, nitro group, phenoxy group, cyano group,...
03/11/1997
5610319Compound useful as antiproliferative agents and GARFT inhibitors
The invention generally relates to compounds of the formula I, which are in equilibrium with their 4-hydroxy tautomers, and their pharmaceutically acceptable salts: ##STR1## where n is 0 to 2; A is S, CH2, O, NH or Se, and when n is 0, A i...
03/11/1997
5594152Process for the preparation of tricyclic-heterocycles
This invention comprises a process for production of a compound of the formula: ##STR1## in which R1 is selected from the group consisting of H, lower alkyl(C1 -C3), alkoxy(C1 -C3), bromo, chloro...
01/14/1997
5591756LTB4 synthesis inhibitors
This invention relates to a compound of the formula: ##STR1## or a pharmaceutically acceptable salt thereof wherein X is oxygen, sulfur, --CH.dbd.CH--, or --CH.dbd.N--; wherein R1 is --CO2 R2 or tetrazole; wherein R2
01/07/1997
5585486Peptidic ketones as interleukin-1ଲ-converting enzyme inhibitors
Disclosed are compounds of the formula (I) and pharmaceutically acceptable salts thereof: ##STR1## wherein R1 is (CR5 R6)n, (CR5 R6)n,-aryl, (CR5 R6)
12/17/1996
5463083Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
2,5-Diaryl tetrahydrofurans, 2,5-diaryl tetrahydrothiophenes, 1,3-diaryl cyclopentanes are disclosed that reduce the chemotaxis and respiratory burst leading to the formation of damaging oxygen radicals of polymorphonuclear leukocytes during an inflammato...
10/31/1995
5457237Dihydroxyindanone tyrosine kinase inhibitors
Certain dihydroxyindanone compounds, and their pharmaceutically-acceptable salts, are inhibitors of tyrosine kinase enzymes, and so are useful for the control of tyrosine kinase dependent diseases (e.g., cancer, atherosclerosis)....
10/10/1995
5446067Oxime ethers and fungicides containing them
Oxime ethers of the formula ##STR1## wherein m, G, R, R1, X, Y, and Z are as defined herein and fungicides containing these compounds....
08/29/1995
5434151Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
2,5-Diaryl tetrahydrofurans, 2,5-diaryl tetrahydrothiophenes, 2,4-diaryl tetrahydrofurans, 2,4-diaryl tetrahydrothiophenes, 1,3-diaryl cyclopentanes, 2,4-diaryl pyrrolidines, and 2,5-diaryl pyrrolidines are disclosed that reduce the chemotaxis and respira...
07/18/1995
5358938Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
2,5-Diaryl tetrahydrofurans, 2,5-diaryl terahydrothiophenes, 2,4-diaryl tetrahydrofurans, 2,4-diaryl tetrahydrothiphenes, 1,3-diaryl cyclopentanes, 2,4-diaryl pyrrolidines, and 2,5-diaryl pyrrolidines are disclosed that reduce the chemotaxis and respirato...
10/25/1994
1        
 
Sign InRegister
Username  
Password   
forgot password?